MedTrace Logo

The Role of Epicardial Adiposity in Heart Failure With Preserved Ejection Fraction

NCT06768437 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2026-04-30

No results posted yet for this study

Summary

In this study the investigators are aiming to recruit 130 patients with heart failure with preserved ejection fraction who are obese and non-obese to undergo CT and MRI scans, as well as some other investigations including blood tests, to help investigate if having more fat around the heart leads to worse heart function in this condition. This may lead to the development of new treatments aimed at lowering fat levels around the heart and in the rest of the body, specifically to treat HFpEF.

Conditions

  • Heart Failure With Preserved Ejection Fraction (HFPEF)

Sponsors & Collaborators

  • University of Leicester

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-12
Primary Completion
2027-08-31
Completion
2037-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06768437 on ClinicalTrials.gov